Australia markets closed

Regeneron Pharmaceuticals, Inc. (REGN)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
742.30+1.12 (+0.15%)
At close: 04:00PM EST
742.30 0.00 (0.00%)
After hours: 06:09PM EST
Currency in USD
Earnings estimateCurrent qtr. (Dec 2022)Next qtr. (Mar 2023)Current year (2022)Next year (2023)
No. of analysts2092425
Avg. Estimate10.1610.0642.741.61
Low estimate5.128.6237.5130.06
High estimate12.6911.1545.5149.6
Year ago EPS21.3211.4973.642.7
Revenue estimateCurrent qtr. (Dec 2022)Next qtr. (Mar 2023)Current year (2022)Next year (2023)
No. of analysts20102424
Avg. Estimate3.16B3B11.88B12.48B
Low estimate2.72B2.89B11.42B11.26B
High estimate3.47B3.14B12.23B13.38B
Year ago sales4.95B2.97B16.07B11.88B
Sales growth (year/est)-36.30%1.30%-26.10%5.00%
Earnings history30/12/202130/03/202229/06/202229/09/2022
Est. EPS18.359.748.849.48
Actual EPS21.3211.499.7711.14
Difference2.971.750.931.66
Surprise %16.20%18.00%10.50%17.50%
EPS trendCurrent qtr. (Dec 2022)Next qtr. (Mar 2023)Current year (2022)Next year (2023)
Current estimate10.1610.0642.741.61
7 days ago10.3410.142.8841.74
30 days ago10.6110.3143.0642
60 days ago10.6110.3143.0441.86
90 days ago10.3210.6341.2143.44
EPS revisionsCurrent qtr. (Dec 2022)Next qtr. (Mar 2023)Current year (2022)Next year (2023)
Up last 7 daysN/AN/AN/A1
Up last 30 daysN/AN/A13
Down last 7 daysN/AN/AN/AN/A
Down last 30 days5153
Growth estimatesREGNIndustrySector(s)S&P 500
Current qtr.-52.30%N/AN/AN/A
Next qtr.-12.40%N/AN/AN/A
Current year-42.00%N/AN/AN/A
Next year-2.60%N/AN/AN/A
Next 5 years (per annum)-16.60%N/AN/AN/A
Past 5 years (per annum)28.06%N/AN/AN/A